H.C. Wainwright has raised the Vir Biotechnology Inc (NASDAQ:VIR) price target to $200 from $135, suggesting an upside of 330%. Analyst Patrick Trucchio…
RBC Capital analyst Ashish Sabadra raised the Cintas Corp (NASDAQ:CTAS) price target to $475 (an upside of 11.7%) from $450 and maintained an Outperform…
Analysts shared different views after Twitter Inc (NYSE:TWTR) announced that co-founder and CEO Jack Dorsey would resign effective immediately and appointed CTO…
Loop Capital analyst Alan Gould lowered the price target on The Walt Disney Co (NYSE: DIS) to $190 from $205, implying a 28.5% upside, but reiterated a Buy.